Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015

被引：0
|
作者：
Young June Choe
Emmanuel Vidor
Christine Manson
机构：
[1] Medical Affairs,
[2] Sanofi,undefined
[3] Global Medical Affairs,undefined
[4] Sanofi,undefined
[5] Global Pharmacovigilance,undefined
[6] Sanofi,undefined
来源：
Infectious Diseases and Therapy | 2022年 / 11卷
关键词：
Diphtheria; DTaP-IPV; Pertussis; Polio; Post-marketing surveillance; Safety; Tetanus; TETRAXIM™; Vaccines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1479 / 1492
页数：13
相关论文
共 46 条
  • [21] Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV) (vol 208, pg 275, 2013)
    Okada, Kenji
    Miyazaki, Chiaki
    Kino, Yoichiro
    Ozaki, Takao
    Hirose, Mizuo
    Ueda, Kohji
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (08): : 1446 - 1448
  • [22] Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis-inactivated Poliovirus Vaccine to Girls and Young Women
    Garcia-Sicilia, Jose
    Schwarz, Tino F.
    Carmona, Alfonso
    Peters, Klaus
    Malkin, Jean-Elie
    Tran, Phu M.
    Behre, Ulrich
    Iturbe, Enrique B.
    Catteau, Gregory
    Thomas, Florence
    Dobbelaere, Kurt
    Descamps, Dominique
    Dubin, Gary
    JOURNAL OF ADOLESCENT HEALTH, 2010, 46 (02) : 142 - 151
  • [23] Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age
    Kitchin, N. R. E.
    Southern, J.
    Morris, R.
    Hemme, F.
    Thomas, S.
    Watson, M. W.
    Cartwright, K.
    Miller, E.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (01) : 11 - 16
  • [24] Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study
    Dang Duc Anh
    Van Der Meeren, Olivier
    Karkada, Naveen
    Assudani, Deepak
    Yu, Ta-Wen
    Han, Htay Htay
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) : 655 - 657
  • [25] Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children:: a randomized double-blind study
    Halperin, SA
    McDonald, J
    Samson, L
    Danzig, L
    Santos, G
    Izu, A
    Smith, B
    MacDonald, N
    CLINICAL AND INVESTIGATIVE MEDICINE, 2002, 25 (06): : 243 - 251
  • [26] Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life
    Kanra, G
    Silier, T
    Yurdakök, K
    Yavuz, T
    Baskan, S
    Ulukol, B
    Ceyhan, M
    Özmert, E
    Türkay, F
    Pehlivan, T
    VACCINE, 1999, 18 (9-10) : 947 - 954
  • [27] Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society
    Russo, Rocco
    Bozzola, Elena
    Villani, Alberto
    VACCINE, 2019, 37 (30) : 3944 - 3944
  • [28] Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination
    Pichichero, ME
    Blatter, MM
    Reisinger, KS
    Harrison, CJ
    Johnson, CE
    Steinhoff, MC
    Senders, SD
    Rothstein, EP
    Willems, P
    Howe, BJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (09) : 854 - 859
  • [29] Post-Marketing Surveillance of Hepatitis A Virus Vaccine (AvaximA® 160U) in South Korea from 2011 to 2015
    Kim, HeeSoo
    Oh, Yongho
    Thollot, Yael
    Bravo, Catherine
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (01) : 105 - 112
  • [30] Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015
    HeeSoo Kim
    Yongho Oh
    Yael Thollot
    Catherine Bravo
    Infectious Diseases and Therapy, 2019, 8 : 105 - 112
12345